Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Chombo cha Kuchunguza Dalili za Kabla ya Hedhi× | Dodoso la Ubora wa Maisha Mahususi kwa Kukoma Hedhi× | |
|---|---|---|
| Nyanja | Uzazi na Magonjwa ya Wanawake | Uzazi na Magonjwa ya Wanawake |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2003 | 1996 |
| Mwanzilishi≠ | Steiner, M., Macdougall, M., & Brown, E. | Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H. |
| Aina | Self-report | Self-report |
| Chanzo asilia≠ | Steiner, M., Macdougall, M., & Brown, E. (2003). The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Archives of Women's Mental Health, 6(3), 203-209. DOI ↗ | Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H., Lethargy, S., & Improvement, T. (1996). A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas, 24(3), 161-175. DOI ↗ |
| Majina mbadala | PSST, Premenstrual Symptom Screening | MENQOL, Menopause Quality of Life |
| Zinazohusiana | 3 | 3 |
| Muhtasari≠ | The Premenstrual Symptoms Screening Tool (PSST) is a brief, 19-item self-report questionnaire designed to screen for premenstrual dysphoric disorder (PMDD) and assess the severity of premenstrual symptoms. Developed by Steiner, Macdougall, and Brown in 2003, the PSST efficiently identifies women with clinically significant cyclical mood and physical symptoms warranting diagnostic evaluation and potential pharmacological or psychological treatment. | The Menopause-Specific Quality of Life Questionnaire (MENQOL) is a 29-item self-report instrument designed to assess quality of life in women experiencing menopausal symptoms. Developed by Hilditch and colleagues in 1996, the MENQOL captures four interrelated symptom domains: vasomotor symptoms (hot flushes, night sweats), psychosocial symptoms (mood, stress, anxiety), physical symptoms (fatigue, aches, sleep), and sexual symptoms. It is the primary menopause-specific outcome measure used in hormone replacement therapy trials and menopause research. |
| ScholarGateSeti ya data ↗ |
|
|